From Beckman Coulter Life Sciences - Flow Cytometry Mar 5 2025 Partnership Expands Oncology Research Possibilities. Image Credit: Beckman Coulter Life Sciences Beckman Coulter Life Sciences , a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research. Under a co-exclusive distribution agreement between the two companies, Beckman Coulter